Skip to main content

Advertisement

SpringerLink
Log in

Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

Decreased expression of epithelial cadherin (E-cadherin) has been noted to associate with aggressiveness and metastasis of breast cancer. The aim of this study was to examine the effect of C-Terminal EH domain-containing protein 2 (EHD2) expression on E-cadherin and related mechanism in the metastasis of breast cancer. Immunohistochemical analysis was performed in 96 human breast carcinoma samples and the data were correlated with clinicopathologic characteristics. Furthermore, Western blot analysis was performed for EHD2 and E-cadherin in breast carcinoma samples and cell lines to evaluate their protein levels and molecular interaction. We found that the expression of EHD2 was positively related with E-cadherin expression (P < 0.01), moreover, EHD2 expression was significantly correlated with histologic grade (P < 0.01). Meanwhile, E-cadherin expression obtained similar results. Kaplan–Meier survival analysis showed that decreased expression of EHD2 and E-cadherin exhibited a significant correlation with poor prognosis in human breast cancer (P < 0.01). While in vitro, we employed siRNA technique to knock down EHD2 expressions and observed their effects on breast cancer cells growth. EHD2 depletion by siRNA promoted PCNA expression, and it was concurrent with the decreased expression of epithelial marker E-cadherin and the increased expression of N-cadherin by Western blot analysis. Consistent with these observations, the suppression of EHD2 in breast cancer cells remarkably promoted cellular proliferation and migration. On the basis of these results, we suggested that EHD2 can inhibit the metastasis of human breast cancer by regulating the EMT key markers E-cadherin and N-cadherin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Adamczyk A, Niemiec JA, Ambicka A, Mucha-Malecka A, Mitus J, Rys J (2014) CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy. J Mol Histol 45(1):35–45. doi:10.1007/s10735-013-9523-6

    Article  CAS  PubMed  Google Scholar 

  • Bignotti E, Tassi RA, Calza S, Ravaggi A, Romani C, Rossi E, Falchetti M, Odicino FE, Pecorelli S, Santin AD (2006) Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 103(2):405–416. doi:10.1016/j.ygyno.03.056

    Article  CAS  PubMed  Google Scholar 

  • Braun A, Pinyol R, Dahlhaus R, Koch D, Fonarev P, Grant BD, Kessels MM, Qualmann B (2005) EHD proteins associate with syndapin I and II and such interactions play a crucial role in endosomal recycling. Mol Biol Cell 16(8):3642–3658. doi:10.1091/mbc.E05-01-0076

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Chen X, Halberg RB, Burch RP, Dove WF (2008) Intestinal adenomagenesis involves core molecular signatures of the epithelial-mesenchymal transition. J Mol Histol 39(3):283–294. doi:10.1007/s10735-008-9164-3

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Cobanoglu U, Ersoz S, Turgutalp H, Reis A, Ozoran Y (2004) Correlation of E-cadherin expression with clinicopathological parameters in breast carcinoma. Saudi Med J 25(8):1024–1027

    PubMed  Google Scholar 

  • Cowin P, Rowlands TM, Hatsell SJ (2005) Cadherins and catenins in breast cancer. Curr Opin Cell Biol 17(5):499–508. doi:10.1016/j.ceb.2005.08.014

    Article  CAS  PubMed  Google Scholar 

  • De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200(4):429–447. doi:10.1002/path.1398

    Article  PubMed  Google Scholar 

  • Guilherme A, Soriano NA, Bose S, Holik J, Bose A, Pomerleau DP, Furcinitti P, Leszyk J, Corvera S, Czech MP (2004) EHD2 and the novel EH domain binding protein EHBP1 couple endocytosis to the actin cytoskeleton. J Biol Chem 279(11):10593–10605. doi:10.1074/jbc.M307702200

    Article  CAS  PubMed  Google Scholar 

  • Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84(3):345–357. doi:10.1016/S0092-8674(00)81279-9

    Article  CAS  PubMed  Google Scholar 

  • Hirata K, Ajiki T, Okazaki T, Horiuchi H, Fujita T, Kuroda Y (2006) Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis. Oncology 71(1–2):102–110. doi:10.1159/000100478

    CAS  PubMed  Google Scholar 

  • Hortobagyi GN, de la Garza SalazarJ, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, O’Shaughnessy JA, Shen ZZ, Albain KS (2005) The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer 6(5):391–401

    Article  PubMed  Google Scholar 

  • Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW (2007) Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression. J Cell Physiol 213(2):374–383. doi:10.1002/jcp.21223

    Article  CAS  PubMed  Google Scholar 

  • Kowalski PJ, Rubin MA, Kleer CG (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5(6):R217–R222. doi:10.1186/bcr651

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Li M, Yang X, Zhang J, Shi H, Hang Q, Huang X, Liu G, Zhu J, He S, Wang H (2013) Effects of EHD2 interference on migration of esophageal squamous cell carcinoma. Med Oncol 30(1):396. doi:10.1007/s12032-012-0396-4

    Article  PubMed Central  PubMed  Google Scholar 

  • Liu X, Ni Q, Xu J, Sheng C, Wang Q, Chen J, Yang S, Wang H (2014) Expression and prognostic role of SKIP in human breast carcinoma. J Mol Histol 45(2):169–180. doi:10.1007/s10735-013-9546-z

    Article  CAS  PubMed  Google Scholar 

  • Makkonen M, Bertling E, Chebotareva NA, Baum J, Lappalainen P (2013) Mammalian and malaria parasite cyclase-associated proteins catalyze nucleotide exchange on G-actin through a conserved mechanism. J Biol Chem 288(2):984–994. doi:10.1074/jbc.M112.435719

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Naslavsky N, Boehm M, Backlund PS, Caplan S (2004) Rabenosyn-5 and EHD1 interact and sequentially regulate protein recycling to the plasma membrane. Mol Biol Cell 15(5):2410–2422. doi:10.1091/mbc.E03-10-0733

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Naslavsky N, Caplan S (2011) EHD proteins: key conductors of endocytic transport. Trends Cell Biol 21(2):122–131. doi:10.1016/j.tcb.2010.10.003

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J, Lee AV (2003) Estrogen-mediated down-regulation of E-cadherin in breast cancer cells. Cancer Res 63(17):5203–5208

    CAS  PubMed  Google Scholar 

  • Pena C, Garcia JM, Silva J, Garcia V, Rodriguez R, Alonso I, Millan I, Salas C, de Herreros AG, Munoz A, Bonilla F (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum Mol Genet 14(22):3361–3370. doi:10.1093/hmg/ddi366

    Article  CAS  PubMed  Google Scholar 

  • Perez-Moreno M, Jamora C, Fuchs E (2003) Sticky business: orchestrating cellular signals at adherens junctions. Cell 112(4):535–548. doi:10.1016/S0092-8674(03)00108-9

    Article  CAS  PubMed  Google Scholar 

  • Picciano JA, Ameen N, Grant BD, Bradbury NA (2003) Rme-1 regulates the recycling of the cystic fibrosis transmembrane conductance regulator. Am J Physiol Cell Physiol 285(5):C1009–C1018. doi:10.1152/ajpcell.00140.2003

    Article  CAS  PubMed  Google Scholar 

  • Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O’Brien TJ, Tian E, Cannon MJ, Shaughnessy J, Pecorelli S (2004) Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112(1):14–25. doi:10.1002/ijc.20408

    Article  CAS  PubMed  Google Scholar 

  • Smith JS, Tachibana I, Pohl U, Lee HK, Thanarajasingam U, Portier BP, Ueki K, Ramaswamy S, Billings SJ, Mohrenweiser HW, Louis DN, Jenkins RB (2000) A transcript map of the chromosome 19q-arm glioma tumor suppressor region. Genomics 64(1):44–50. doi:10.1006/geno.1999.6101

    Article  CAS  PubMed  Google Scholar 

  • Wittekind C, Neid M (2005) Cancer invasion and metastasis. Oncology 69(suppl 1):14–16. doi:10.1159/000086626

    Article  PubMed  Google Scholar 

  • Zhu T, Ji Z, Xu C, Peng Z, Gu L, Zhang R, Liu Y (2014) Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation. J Mol Histol 45(6):665–677. doi:10.1007/s10735-014-9586-z

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Special thanks to the department of Pathology, Affiliated Yancheng Hospital of Southeast University for helping with the statistical analysis. Furthermore, I would like to thank Jiahui Chen for help and encouragement.

Conflicts of interest

The authors declare that they have no conflict of interests.

Author information

Author notes

    Authors and Affiliations

    1. Department of General Surgery, Affiliated Yancheng Hospital of Southeast University, Yancheng, 224001, Jiangsu, People’s Republic of China

      Yuhua Shi, Xiaobing Liu, Yongfang Sun, Dichen Wu, Aifeng Qiu, Haiyan Cheng, Cuigan Wu & Xuebin Wang

    Authors
    1. Yuhua Shi
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Xiaobing Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Yongfang Sun
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Dichen Wu
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Aifeng Qiu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Haiyan Cheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Cuigan Wu
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Xuebin Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Xuebin Wang.

    Additional information

    Yuhua Shi and Xiaobing Liu has been contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Shi, Y., Liu, X., Sun, Y. et al. Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin. J Mol Hist 46, 221–231 (2015). https://doi.org/10.1007/s10735-015-9614-7

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s10735-015-9614-7

    Keywords

    Search

    Navigation